ScreenerHero

PBLAPanbela Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · panbela.com
0.0001USD0.00%Mkt Cap: 485 $P/E: —

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product cand…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap485 $
Enterprise Value1.67M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.26M $
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS69833W2061
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-34.51
EPS (Forward)-5.66
52W Range
0.00010% of range2.500
52W High2.500 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE536.37%
ROA-214.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.25M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1645360.82%
Net Debt1.67M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-1.10
Current Ratio0.26
Quick Ratio0.25
Book Value/Sh-3.7420 USD
Cash/Share0.9740 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 8, 2017
Splits
Last Split1:20
Split DateJan 18, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.85M
Float4.85M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float3.07%
Short % Out.3.07%
Shares Short106.97K
Short (prev mo.)46.36K
Technical
SMA 500.0082 (-98.8%)
SMA 2000.0075 (-98.7%)
Beta43.61
S&P 52W Chg18.16%
Avg Vol (30d)191
Avg Vol (10d)225
Technical Indicators
RSI (14)14.2
MACD-0.0026
MACD Signal-0.0014
MACD Hist.-0.0012
BB Upper0.0180 USD
BB Middle0.0073 USD
BB Lower-0.0035 USD
BB Width296.99%
ATR (14)0.0007 USD
Vol Ratio (20d)0.94x